Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain.
Fundamental & clinical pharmacology 2016 Apr 30 (2): 153-61.
de Moraes Natália V, Lauretti Gabriela R, Coelho Eduardo B, Godoy Ana Leonor P C, Neves Daniel V, Lanchote Vera
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: